Felix Beuschlein, MD

University of Munich
Med. Klinik und Poliklinik IV

Biographical Sketch:
EDUCATION 1990-1996 Medical School, University of Würzburg, Germany 11/96 Graduation from Medical School (MD degree) 16.12.97 Doctoral degree by the Faculty of Medicine, University of Würzburg 1/97-6/98 Internship at the Dept. of Internal Medicine, University of Würzburg 7/98-7/00 Residency in Internal Medicine/Endocrinology at the Dept. of Internal Medicine, Endocrinology Division, University of Freiburg, Germany 7/00-7/02 Postdoctoral fellow at the University of Michigan, Ann Arbor 7/02-1/05 Completion of residency in Internal Medicine/Endocrinology at the Dept. of Internal Medicine, University of Freiburg as of 01/05 Attending Physician / Consultant as of 07/05 Provisional Head of Division for Endocrinology and Diabetology, University of Freiburg as of 06/06 Head of Endocrine Research, University of Munich as of 10/11 Head of Endocrine Outpatient Clinic OTHER PROFESSIONAL ACTIVITIES 03/99 Co-founder of a supporting organization for young researcher in the field of Endocrinology (“DGE-Junge Forschung aktiv”, YARE) 10/02 Organization of the 2002 Meeting of the 4. Perspective Conference, Freiburg 12/06 Organization of the 4. Meeting of the European Network for the Study of Adrenal Tumors (ENS@T), Munich 06/03 Co-founder and advisory board member of “Adrenal, Hypertension and Steroids” (Section of the German Endocrine Society) 2006-2011 Chairman as of 12/07 Member of the Steering committee of the European Network for the Study of Adrenal Tumors (ENS@T) as of 2008 Chairman as of 2007 Editorial Board member of Journal of Molecular Endocrinology as of 2007 Editorial Board member of Journal of Endocrinology 2010 Member of the Program committee for the 2011 International Adrenocortical Cancer Meeting, Würzburg as of 01/11 Coordinator of an FP7 Consortium (ENS@T-CANCER) as of 06/11 Vice president of the German Endocrine Society (DGE) as of 05/08 Scientific advisory board of Orphanet Germany as of 02/12 Member of the Research Affairs Core Committee of the Endocrine Society
Papers:
FP29-1 Investigation of novel chemotherapeutic combinations in a tumor model for adrenocortical carcinoma
OR29-3 Prognostic value of histological markers in localized adrenocortical carcinoma after complete resection
OR29-4 Biochemical diagnosis of pheochromocytoma using plasma free normetanephrine, metanephrine and methoxytyramine: Importance of supine sampling under fasting conditions
S30 Whats New in Primary Aldosteronism?
S30-3 Novel Genes in Primary Aldosteronism